Anna-Maria Fink

5PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersInnate immunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Nov 27, 2024
Ibrutinib in Early-Stage Chronic Lymphocytic Leukemia: The Randomized, Placebo-Controlled, Double-Blind, Phase III CLL12 Trial.

Petra Langerbeins, Sandra Robrecht, Pascal Nieper

|Aug 30, 2024
End Point Surrogacy in First-Line Chronic Lymphocytic Leukemia.

Florian Simon, Rudy Ligtvoet, Sandra Robrecht

|Feb 04, 2024
Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia.

Sibylle C Mellinghoff, Sandra Robrecht, Rosanne Sprute

|May 20, 2022
Circulating Tumor DNA-Based MRD Assessment in Patients with CLL Treated with Obinutuzumab, Acalabrutinib, and Venetoclax.

Moritz Fürstenau, Jonathan Weiss, Adam Giza

Pageof 1

Frequent Collaborators

4 joint publications

Petra Langerbeins

3 joint publications

Moritz Fürstenau

3 joint publications

Michael Hallek

2 joint publications

Sibylle C Mellinghoff